Inactivation of GAPDH as one mechanism of acrolein toxicity

Biochemical and Biophysical Research Communications

Volumn 430, Issue 4, 2013, Pages 1265-1271

  Nakamura, Mizuho ^a   Tomitori, Hideyuki ^a   Suzuki, Takehiro ^b   Sakamoto, Akihiko ^a   Terui, Yusuke ^a   Saiki, Ryotaro ^c   Dohmae, Naoshi ^b   Igarashi, Kazuei ^c   Kashiwagi, Keiko ^a  

^a CHIBA INSTITUTE OF SCIENCE   (Japan)

^b RIKEN   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Acrolein; GAPDH; Nuclear translocation; TUNEL assay

Indexed keywords

ACROLEIN; ADENOSINE TRIPHOSPHATE; CYSTEINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE;

ACETYLATION; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BIOTRANSFORMATION; BREAST CARCINOMA; CARCINOMA CELL; CELL DEATH; CELL NUCLEUS; CONJUGATE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME INACTIVATION; GEL ELECTROPHORESIS; IMMUNOCYTOCHEMISTRY; MASS SPECTROMETRY; MOUSE; NEUROBLASTOMA CELL; NICK END LABELING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ACROLEIN; AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CYSTEINE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; MICE; MOLECULAR SEQUENCE DATA; TRANSFORMATION, GENETIC;

EID: 84872857071     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.057     Document Type: Article

References (32)

1. Hensley K., Robinson K.A., Gabbita S.P., Salsman S., Floyd R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 2000, 28:1456-1462.
2. Sharmin S., Sakata K., Kashiwagi K., Ueda S., Iwasaki S., Shirahata A., Igarashi K. Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem. Biophys. Res. Commun. 2001, 282:228-235.
3. Yoshida M., Tomitori H., Machi Y., Hagihara M., Higashi K., Goda H., Ohya T., Niitsu M., Kashiwagi K., Igarashi K. Acrolein toxicity: comparison with reactive oxygen species. Biochem. Biophys. Res. Commun. 2009, 378:313-318.
4. Uchida K., Kanematsu M., Morimitsu Y., Osawa T., Noguchi N., Niki E. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 1998, 273:16058-16066.
5. Tomitori H., Usui T., Saeki N., Ueda S., Kase H., Nishimura K., Kashiwagi K., Igarashi K. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke 2005, 36:2609-2613.
6. Saiki R., Nishimura K., Ishii I., Omura T., Okuyama S., Kashiwagi K., Igarashi K. Intense correlation between brain infarction and protein-conjugated acrolein. Stroke 2009, 40:3356-3361.
7. Saiki R., Park H., Ishii I., Yoshida M., Nishimura K., Toida T., Tatsukawa H., Kojima S., Ikeguchi Y., Pegg A.E., Kashiwagi K., Igarashi K. Brain infarction correlates more closely with acrolein than with reactive oxygen species. Biochem. Biophys. Res. Commun. 2011, 404:1044-1049.
8. Igarashi K., Kashiwagi K. Modulation of cellular function by polyamines. Int. J. Biochem. Cell Biol. 2010, 42:39-51.
9. Cervelli M., Polticelli F., Federico R., Mariottini P. Heterologous expression and characterization of mouse spermine oxidase. J. Biol. Chem. 2003, 278:5271-5276.
10. Wang Y., Casero R.A. Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?. J. Biochem. 2006, 139:17-25.
11. Igarashi K., Kashiwagi K. Protein-conjugated acrolein as a biochemical marker of brain infarction. Mol. Nutr. Food Res. 2011, 55:1332-1341.
12. Yoshida M., Higashi K., Kobayashi E., Saeki N., Wakui K., Kusaka T., Takizawa H., Kashiwado K., Suzuki N., Fukuda K., Nakamura T., Watanabe S., Tada K., Machi Y., Mizoi M., Toida T., Kanzaki T., Tomitori H., Kashiwagi K., Igarashi K. Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis 2010, 211:475-479.
13. Stevens J.F., Maier C.S. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 2008, 52:7-25.
14. Aldini G., Orioli M., Carini M. Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents. Mol. Nutr. Food Res. 2011, 55:1301-1319.
15. Tristan C., Shahani N., Sedlak T.W., Sawa A. The diverse functions of GAPDH: views from different subcellular compartments. Cell Signal. 2011, 23:317-323.
16. Ayusawa D., Koyama H., Iwata K., Seno T. Selection of mammalian thymidine auxotrophic cell mutants defective in thymidylate synthase by their reduced sensitivity to methotrexate. Somatic Cell Genet. 1981, 7:523-534.
17. Tomitori H., Nakamura M., Sakamoto A., Terui Y., Yoshida M., Igarashi K., Kashiwagi K. Augmented glutathione synthesis decreases acrolein toxicity. Biochem. Biophys. Res. Commun. 2012, 418:110-115.
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
19. Nishimura K., Okudaira H., Ochiai E., Higashi K., Kaneko M., Ishii I., Nishimura T., Dohmae N., Kashiwagi K., Igarashi K. Identification of proteins whose synthesis is preferentially enhanced by polyamines at the level of translation in mammalian cells. Int. J. Biochem. Cell Biol. 2009, 41:2251-2261.
20. Cai J., Bhatnagar A., Pierce W.M. Protein modification by acrolein: formation and stability of cysteine adducts. Chem. Res. Toxicol. 2009, 22:708-716.
21. Yoshida M., Higashi K., Jin L., Machi Y., Suzuki T., Masuda A., Dohmae N., Suganami A., Tamura Y., Nishimura K., Toida T., Tomitori H., Kashiwagi K., Igarashi K. Identification of acrolein-conjugated protein in plasma of patients with brain infarction. Biochem. Biophys. Res. Commun. 2010, 391:1234-1239.
22. Park C.W., Zeng Y., Zhang X., Subramanian S., Steer C.J. Mature microRNAs identified in highly purified nuclei from HCT116 colon cancer cells. RNA Biol. 2010, 7:606-614.
23. Bradley M.A., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic. Biol. Med. 2010, 48:1570-1576.
24. Dalle-Donne I., Carini M., Vistoli G., Gamberoni L., Giustarini D., Colombo R., Maffei Facino R., Rossi R., Milzani A., Aldini G. Actin Cys374 as a nucleophilic target of α, β-unsaturated aldehydes. Free Radic. Biol. Med. 2007, 42:583-598.
25. Bae B.I., Hara M.R., Cascio M.B., Wellington C.L., Hayden M.R., Ross C.A., Ha H.C., Li X.J., Snyder S.H., Sawa A. Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH. Proc. Natl. Acad. Sci. USA 2006, 103:3405-3409.
26. Sen N., Hara M.R., Kornberg M.D., Cascio M.B., Bae B.I., Shahani N., Thomas B., Dawson T.M., Dawson V.L., Snyder S.H., Sawa A. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat. Cell Biol. 2008, 10:866-873.
27. Han B., Stevens J.F., Maier C.S. Design, synthesis, and application of a hydrazide-functionalized isotope-coded affinity tag for the quantification of oxylipid-protein conjugates. Anal. Chem. 2007, 79:3342-3354.
28. Lambert C., Li J., Jonscher K., Yang T.C., Reigan P., Quintana M., Harvey J., Freed B.M. Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-κB1 DNA binding domain. J. Biol. Chem. 2007, 282:19666-19675.
29. Seiner D.R., LaButti J.N., Gates K.S. Kinetics and mechanism of protein tyrosine phosphatase 1B inactivation by acrolein. Chem. Res. Toxicol. 2007, 20:1315-1320.
30. Nakajima H., Amano W., Fujita A., Fukuhara A., Azuma Y.T., Hata F., Inui T., Takeuchi T. The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death. J. Biol. Chem. 2007, 282:26562-26574.
31. Luo J., Robinson J.P., Shi R. Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem. Int. 2005, 47:449-457.
32. Sun L., Luo C., Long J., Wei D., Liu J. Acrolein is a mitochondrial toxin: effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Mitochondrion 2006, 6:136-142.